Scarpa et al. Molecular approach in human tumor investigation: oncogenes, tumor suppressor genes and DNA tumor polyomaviruses (review). Int J Mol Med. Jun. 1998, vol. 1, pp. 1011-1023.* |
Tani et al. Human M2-type pyruvate kinase mRNA. Accession No. M23725. Apr. 27, 1993.* |
Eigenbrodt et al. Quantification of tumor type M2 pyruvate kinase (Tu M2-PK) in human carcinomas. Anticancer Res. Jul.-Aug. 1997, vol. 17, pp. 3153-3156.* |
Hennipman et al. Glycolytic enzymes in breast cancer, benign breast disease and normal breast tissue. Tumour Biol. 1987, vol. 8, pp. 251-263.* |
Melnikow J et al. Cancer prevention and screening in women. Prim Care. Mar. 1997, vol. 24, pp. 15-26.* |
Evans et al. Correlations between the mammographic features of ductal carcinoma in situ (DCIS) and C-erbB-2 oncogene expression. Nottingham Breast Team. Clin Radiol. Aug. 1994, vol. 49, pp. 559-562.* |
Collins, C. et al., (1998) Positional Cloning of ZNF217 and NABC1: Genes Amplified at 20q13.2 and Overexpressed in Breast Carcinoma. Proceedings of the National Academy of Sciences of the United States of America 95:8703-8. |
Courjal, F. et al., (1996) DNA Amplifications at 20q13 and MDM2 Define Distinct Subsets of Evolved Breast and Ovarian Tumours British Journal of Cancer 74:1984-1989. |
Eigenbrodt, E. et al., (1992) Double role for Pyruvate Kinase Type M2 in the Expansion of Phosphometabolite Pools Found in Tumor Cells. Critical Reviews in Oncogenesis 3:91-115. |
Hacker, H.J. et al., (1998) Pyruvate Kinase Isoenzyme Shift From L-Type to M2-type is a Late Event in Hepatocarcinogenesis Induced in Rats by a Choline-Deficient/DL-Ethionine-Supplemented Diet. Carcinogenesis 19:99-107. |
Tanner, M.M. et al., (1994) Increased Copy Number at 20q13 in Breast Cancer: Defining the Critical Region and Exclusion of Candidate Genes. Cancer Research 54:4257-60. |
Tanner, M.M. et al. (1995) Amplification of Chromosomal Region 20q13 in Invasive Breast Cancer: Prognostic Implications. Clinical Cancer Research 1:1455-1461. |
Zwerschke, W. et al., (1999) Modulation of Type M2 Pyruvate Kinase Activity by the Human Papillomavirus Type 16 E7 Oncoprotein. Proceedings of the National Academy of Sciences of the United States of America 96:1291-6. |